 | • レポートコード：QAF27553 • 出版社/出版日：QYResearch / 2021年4月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のアミノグリコシド系抗生物質市場について種類別（ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチミシン、その他）、用途別（病院、診療所、ポストケア施設、政府＆軍用、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アミノグリコシド系抗生物質市場の概要 ・世界の主要地域別アミノグリコシド系抗生物質市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のアミノグリコシド系抗生物質市場規模2016-2021：種類別（ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチミシン、その他） ・世界のアミノグリコシド系抗生物質市場予測2012-2027：種類別（ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチミシン、その他） ・世界のアミノグリコシド系抗生物質市場規模2016-2021：用途別（病院、診療所、ポストケア施設、政府＆軍用、その他） ・世界のアミノグリコシド系抗生物質市場予測2012-2027：用途別（病院、診療所、ポストケア施設、政府＆軍用、その他） ・アミノグリコシド系抗生物質のアメリカ市場規模と予測2016-2021 ・アミノグリコシド系抗生物質のヨーロッパ市場規模と予測2016-2021 ・アミノグリコシド系抗生物質の中国市場規模と予測2016-2021 ・アミノグリコシド系抗生物質の日本市場規模と予測2016-2021 ・アミノグリコシド系抗生物質の東南アジア市場規模と予測2016-2021 ・アミノグリコシド系抗生物質のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jemicare、Teva、Novartis、Fangyuan-pharma、Aike Pharmaceutical、Cipla、Pfizer、Fresenius Kabi、Sun Pharma、Hikma、Lannett Company） ・アミノグリコシド系抗生物質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アミノグリコシド系抗生物質の市場動向・機会・課題 ・調査の結論 |
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.
Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.
Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.
Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.
Market Analysis and Insights: Global Aminoglycosides Antibiotics Market
The global Aminoglycosides Antibiotics market was valued at US$ 1051.5 in 2020 and will reach US$ 1083.5 million by the end of 2027, growing at a CAGR of 0.5% during 2022-2027.
Global Aminoglycosides Antibiotics Scope and Market Size
The global Aminoglycosides Antibiotics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aminoglycosides Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Segment by Application
Hospital
Clinic
Post Care Facility
Government & Military
Others
The Aminoglycosides Antibiotics market is analysed and market size information is provided by regions (countries). Segment by Application, the Aminoglycosides Antibiotics market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
1 Aminoglycosides Antibiotics Market Overview
1.1 Aminoglycosides Antibiotics Product Scope
1.2 Aminoglycosides Antibiotics Segment by Type
1.2.1 Global Aminoglycosides Antibiotics Sales by Type (2016 & 2021 & 2027)
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Etimicin
1.2.7 Others
1.3 Aminoglycosides Antibiotics Segment by Application
1.3.1 Global Aminoglycosides Antibiotics Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Post Care Facility
1.3.5 Government & Military
1.3.6 Others
1.4 Aminoglycosides Antibiotics Market Estimates and Forecasts (2016-2027)
1.4.1 Global Aminoglycosides Antibiotics Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Aminoglycosides Antibiotics Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Aminoglycosides Antibiotics Price Trends (2016-2027)
2 Aminoglycosides Antibiotics Estimates and Forecasts by Region
2.1 Global Aminoglycosides Antibiotics Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Aminoglycosides Antibiotics Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Aminoglycosides Antibiotics Sales Market Share by Region (2016-2021)
2.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Region (2016-2021)
2.3 Global Aminoglycosides Antibiotics Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Aminoglycosides Antibiotics Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Aminoglycosides Antibiotics Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Aminoglycosides Antibiotics Estimates and Projections (2016-2027)
2.4.2 Europe Aminoglycosides Antibiotics Estimates and Projections (2016-2027)
2.4.3 China Aminoglycosides Antibiotics Estimates and Projections (2016-2027)
2.4.4 Japan Aminoglycosides Antibiotics Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Aminoglycosides Antibiotics Estimates and Projections (2016-2027)
2.4.6 India Aminoglycosides Antibiotics Estimates and Projections (2016-2027)
3 Global Aminoglycosides Antibiotics Competition Landscape by Players
3.1 Global Top Aminoglycosides Antibiotics Players by Sales (2016-2021)
3.2 Global Top Aminoglycosides Antibiotics Players by Revenue (2016-2021)
3.3 Global Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics as of 2020)
3.4 Global Aminoglycosides Antibiotics Average Price by Company (2016-2021)
3.5 Manufacturers Aminoglycosides Antibiotics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Aminoglycosides Antibiotics Market Size by Type
4.1 Global Aminoglycosides Antibiotics Historic Market Review by Type (2016-2021)
4.1.1 Global Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
4.1.2 Global Aminoglycosides Antibiotics Revenue Market Share by Type (2016-2021)
4.1.3 Global Aminoglycosides Antibiotics Price by Type (2016-2021)
4.2 Global Aminoglycosides Antibiotics Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Aminoglycosides Antibiotics Sales Forecast by Type (2022-2027)
4.2.2 Global Aminoglycosides Antibiotics Revenue Forecast by Type (2022-2027)
4.2.3 Global Aminoglycosides Antibiotics Price Forecast by Type (2022-2027)
5 Global Aminoglycosides Antibiotics Market Size by Application
5.1 Global Aminoglycosides Antibiotics Historic Market Review by Application (2016-2021)
5.1.1 Global Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
5.1.2 Global Aminoglycosides Antibiotics Revenue Market Share by Application (2016-2021)
5.1.3 Global Aminoglycosides Antibiotics Price by Application (2016-2021)
5.2 Global Aminoglycosides Antibiotics Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Aminoglycosides Antibiotics Sales Forecast by Application (2022-2027)
5.2.2 Global Aminoglycosides Antibiotics Revenue Forecast by Application (2022-2027)
5.2.3 Global Aminoglycosides Antibiotics Price Forecast by Application (2022-2027)
6 North America Aminoglycosides Antibiotics Market Facts & Figures
6.1 North America Aminoglycosides Antibiotics Sales by Company
6.1.1 North America Aminoglycosides Antibiotics Sales by Company (2016-2021)
6.1.2 North America Aminoglycosides Antibiotics Revenue by Company (2016-2021)
6.2 North America Aminoglycosides Antibiotics Sales Breakdown by Type
6.2.1 North America Aminoglycosides Antibiotics Sales Breakdown by Type (2016-2021)
6.2.2 North America Aminoglycosides Antibiotics Sales Breakdown by Type (2022-2027)
6.3 North America Aminoglycosides Antibiotics Sales Breakdown by Application
6.3.1 North America Aminoglycosides Antibiotics Sales Breakdown by Application (2016-2021)
6.3.2 North America Aminoglycosides Antibiotics Sales Breakdown by Application (2022-2027)
7 Europe Aminoglycosides Antibiotics Market Facts & Figures
7.1 Europe Aminoglycosides Antibiotics Sales by Company
7.1.1 Europe Aminoglycosides Antibiotics Sales by Company (2016-2021)
7.1.2 Europe Aminoglycosides Antibiotics Revenue by Company (2016-2021)
7.2 Europe Aminoglycosides Antibiotics Sales Breakdown by Type
7.2.1 Europe Aminoglycosides Antibiotics Sales Breakdown by Type (2016-2021)
7.2.2 Europe Aminoglycosides Antibiotics Sales Breakdown by Type (2022-2027)
7.3 Europe Aminoglycosides Antibiotics Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Aminoglycosides Antibiotics Market Facts & Figures
8.1 China Aminoglycosides Antibiotics Sales by Company
8.1.1 China Aminoglycosides Antibiotics Sales by Company (2016-2021)
8.1.2 China Aminoglycosides Antibiotics Revenue by Company (2016-2021)
8.2 China Aminoglycosides Antibiotics Sales Breakdown by Type
8.2.1 China Aminoglycosides Antibiotics Sales Breakdown by Type (2016-2021)
8.2.2 China Aminoglycosides Antibiotics Sales Breakdown by Type (2022-2027)
8.3 China Aminoglycosides Antibiotics Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Aminoglycosides Antibiotics Market Facts & Figures
9.1 Japan Aminoglycosides Antibiotics Sales by Company
9.1.1 Japan Aminoglycosides Antibiotics Sales by Company (2016-2021)
9.1.2 Japan Aminoglycosides Antibiotics Revenue by Company (2016-2021)
9.2 Japan Aminoglycosides Antibiotics Sales Breakdown by Type
9.2.1 Japan Aminoglycosides Antibiotics Sales Breakdown by Type (2016-2021)
9.2.2 Japan Aminoglycosides Antibiotics Sales Breakdown by Type (2022-2027)
9.3 Japan Aminoglycosides Antibiotics Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Aminoglycosides Antibiotics Market Facts & Figures
10.1 Southeast Asia Aminoglycosides Antibiotics Sales by Company
10.1.1 Southeast Asia Aminoglycosides Antibiotics Sales by Company (2016-2021)
10.1.2 Southeast Asia Aminoglycosides Antibiotics Revenue by Company (2016-2021)
10.2 Southeast Asia Aminoglycosides Antibiotics Sales Breakdown by Type
10.2.1 Southeast Asia Aminoglycosides Antibiotics Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Aminoglycosides Antibiotics Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Aminoglycosides Antibiotics Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Aminoglycosides Antibiotics Market Facts & Figures
11.1 India Aminoglycosides Antibiotics Sales by Company
11.1.1 India Aminoglycosides Antibiotics Sales by Company (2016-2021)
11.1.2 India Aminoglycosides Antibiotics Revenue by Company (2016-2021)
11.2 India Aminoglycosides Antibiotics Sales Breakdown by Type
11.2.1 India Aminoglycosides Antibiotics Sales Breakdown by Type (2016-2021)
11.2.2 India Aminoglycosides Antibiotics Sales Breakdown by Type (2022-2027)
11.3 India Aminoglycosides Antibiotics Sales Breakdown by Application
11.3.1 India Aminoglycosides Antibiotics Sales Breakdown by Application (2016-2021)
11.3.2 India Aminoglycosides Antibiotics Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Aminoglycosides Antibiotics Business
12.1 Jemicare
12.1.1 Jemicare Corporation Information
12.1.2 Jemicare Business Overview
12.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jemicare Aminoglycosides Antibiotics Products Offered
12.1.5 Jemicare Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Aminoglycosides Antibiotics Products Offered
12.2.5 Teva Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Aminoglycosides Antibiotics Products Offered
12.3.5 Novartis Recent Development
12.4 Fangyuan-pharma
12.4.1 Fangyuan-pharma Corporation Information
12.4.2 Fangyuan-pharma Business Overview
12.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Products Offered
12.4.5 Fangyuan-pharma Recent Development
12.5 Aike Pharmaceutical
12.5.1 Aike Pharmaceutical Corporation Information
12.5.2 Aike Pharmaceutical Business Overview
12.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Products Offered
12.5.5 Aike Pharmaceutical Recent Development
12.6 Cipla
12.6.1 Cipla Corporation Information
12.6.2 Cipla Business Overview
12.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cipla Aminoglycosides Antibiotics Products Offered
12.6.5 Cipla Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Aminoglycosides Antibiotics Products Offered
12.7.5 Pfizer Recent Development
12.8 Fresenius Kabi
12.8.1 Fresenius Kabi Corporation Information
12.8.2 Fresenius Kabi Business Overview
12.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Fresenius Kabi Aminoglycosides Antibiotics Products Offered
12.8.5 Fresenius Kabi Recent Development
12.9 Sun Pharma
12.9.1 Sun Pharma Corporation Information
12.9.2 Sun Pharma Business Overview
12.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sun Pharma Aminoglycosides Antibiotics Products Offered
12.9.5 Sun Pharma Recent Development
12.10 Hikma
12.10.1 Hikma Corporation Information
12.10.2 Hikma Business Overview
12.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hikma Aminoglycosides Antibiotics Products Offered
12.10.5 Hikma Recent Development
12.11 Lannett Company
12.11.1 Lannett Company Corporation Information
12.11.2 Lannett Company Business Overview
12.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lannett Company Aminoglycosides Antibiotics Products Offered
12.11.5 Lannett Company Recent Development
13 Aminoglycosides Antibiotics Manufacturing Cost Analysis
13.1 Aminoglycosides Antibiotics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Aminoglycosides Antibiotics
13.4 Aminoglycosides Antibiotics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Aminoglycosides Antibiotics Distributors List
14.3 Aminoglycosides Antibiotics Customers
15 Market Dynamics
15.1 Aminoglycosides Antibiotics Market Trends
15.2 Aminoglycosides Antibiotics Drivers
15.3 Aminoglycosides Antibiotics Market Challenges
15.4 Aminoglycosides Antibiotics Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Aminoglycosides Antibiotics Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Aminoglycosides Antibiotics Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Aminoglycosides Antibiotics Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Aminoglycosides Antibiotics Sales (M Units) by Region (2016-2021)
Table 5. Global Aminoglycosides Antibiotics Sales Market Share by Region (2016-2021)
Table 6. Global Aminoglycosides Antibiotics Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Aminoglycosides Antibiotics Revenue Share by Region (2016-2021)
Table 8. Global Aminoglycosides Antibiotics Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Aminoglycosides Antibiotics Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Aminoglycosides Antibiotics Revenue Share Forecast by Region (2022-2027)
Table 12. Global Aminoglycosides Antibiotics Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Aminoglycosides Antibiotics Sales Share by Company (2016-2021)
Table 14. Global Aminoglycosides Antibiotics Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Aminoglycosides Antibiotics Revenue Share by Company (2016-2021)
Table 16. Global Aminoglycosides Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aminoglycosides Antibiotics as of 2020)
Table 17. Global Aminoglycosides Antibiotics Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Aminoglycosides Antibiotics Manufacturing Sites and Area Served
Table 19. Manufacturers Aminoglycosides Antibiotics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Aminoglycosides Antibiotics Sales (M Units) by Type (2016-2021)
Table 22. Global Aminoglycosides Antibiotics Sales Share by Type (2016-2021)
Table 23. Global Aminoglycosides Antibiotics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Aminoglycosides Antibiotics Price (USD/Unit) by Type (2016-2021)
Table 25. Global Aminoglycosides Antibiotics Sales Share by Type (2022-2027)
Table 26. Global Aminoglycosides Antibiotics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Aminoglycosides Antibiotics Revenue Share by Type (2022-2027)
Table 28. Global Aminoglycosides Antibiotics Price (USD/Unit) by Type (2022-2027)
Table 29. Global Aminoglycosides Antibiotics Sales (M Units) by Application (2016-2021)
Table 30. Global Aminoglycosides Antibiotics Sales Share by Application (2016-2021)
Table 31. Global Aminoglycosides Antibiotics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Aminoglycosides Antibiotics Price (USD/Unit) by Application (2016-2021)
Table 33. Global Aminoglycosides Antibiotics Sales (M Units) by Application (2022-2027)
Table 34. Global Aminoglycosides Antibiotics Sales Share by Application (2022-2027)
Table 35. Global Aminoglycosides Antibiotics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Aminoglycosides Antibiotics Revenue Share by Application (2022-2027)
Table 37. Global Aminoglycosides Antibiotics Price (USD/Unit) by Application (2022-2027)
Table 38. North America Aminoglycosides Antibiotics Sales (M Units) by Company (2016-2021)
Table 39. North America Aminoglycosides Antibiotics Sales Market Share by Company (2016-2021)
Table 40. North America Aminoglycosides Antibiotics Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Aminoglycosides Antibiotics Revenue Market Share by Company (2016-2021)
Table 42. North America Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 43. North America Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 44. North America Aminoglycosides Antibiotics Sales by Type (2022-2027) & (M Units)
Table 45. North America Aminoglycosides Antibiotics Sales Market Share by Type (2022-2027)
Table 46. North America Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 47. North America Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 48. North America Aminoglycosides Antibiotics Sales by Application (2022-2027) & (M Units)
Table 49. North America Aminoglycosides Antibiotics Sales Market Share by Application (2022-2027)
Table 50. Europe Aminoglycosides Antibiotics Sales (M Units) by Company (2016-2021)
Table 51. Europe Aminoglycosides Antibiotics Sales Market Share by Company (2016-2021)
Table 52. Europe Aminoglycosides Antibiotics Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Aminoglycosides Antibiotics Revenue Market Share by Company (2016-2021)
Table 54. Europe Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 55. Europe Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 56. Europe Aminoglycosides Antibiotics Sales by Type (2022-2027) & (M Units)
Table 57. Europe Aminoglycosides Antibiotics Sales Market Share by Type (2022-2027)
Table 58. Europe Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 59. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 60. Europe Aminoglycosides Antibiotics Sales by Application (2022-2027) & (M Units)
Table 61. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2022-2027)
Table 62. China Aminoglycosides Antibiotics Sales (M Units) by Company (2016-2021)
Table 63. China Aminoglycosides Antibiotics Sales Market Share by Company (2016-2021)
Table 64. China Aminoglycosides Antibiotics Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Aminoglycosides Antibiotics Revenue Market Share by Company (2016-2021)
Table 66. China Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 67. China Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 68. China Aminoglycosides Antibiotics Sales by Type (2022-2027) & (M Units)
Table 69. China Aminoglycosides Antibiotics Sales Market Share by Type (2022-2027)
Table 70. China Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 71. China Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 72. China Aminoglycosides Antibiotics Sales by Application (2022-2027) & (M Units)
Table 73. China Aminoglycosides Antibiotics Sales Market Share by Application (2022-2027)
Table 74. Japan Aminoglycosides Antibiotics Sales (M Units) by Company (2016-2021)
Table 75. Japan Aminoglycosides Antibiotics Sales Market Share by Company (2016-2021)
Table 76. Japan Aminoglycosides Antibiotics Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Aminoglycosides Antibiotics Revenue Market Share by Company (2016-2021)
Table 78. Japan Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 79. Japan Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 80. Japan Aminoglycosides Antibiotics Sales by Type (2022-2027) & (M Units)
Table 81. Japan Aminoglycosides Antibiotics Sales Market Share by Type (2022-2027)
Table 82. Japan Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 83. Japan Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 84. Japan Aminoglycosides Antibiotics Sales by Application (2022-2027) & (M Units)
Table 85. Japan Aminoglycosides Antibiotics Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Aminoglycosides Antibiotics Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Aminoglycosides Antibiotics Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Aminoglycosides Antibiotics Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Aminoglycosides Antibiotics Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Aminoglycosides Antibiotics Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Aminoglycosides Antibiotics Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Aminoglycosides Antibiotics Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Aminoglycosides Antibiotics Sales Market Share by Application (2022-2027)
Table 98. India Aminoglycosides Antibiotics Sales (M Units) by Company (2016-2021)
Table 99. India Aminoglycosides Antibiotics Sales Market Share by Company (2016-2021)
Table 100. India Aminoglycosides Antibiotics Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Aminoglycosides Antibiotics Revenue Market Share by Company (2016-2021)
Table 102. India Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 103. India Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 104. India Aminoglycosides Antibiotics Sales by Type (2022-2027) & (M Units)
Table 105. India Aminoglycosides Antibiotics Sales Market Share by Type (2022-2027)
Table 106. India Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 107. India Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 108. India Aminoglycosides Antibiotics Sales by Application (2022-2027) & (M Units)
Table 109. India Aminoglycosides Antibiotics Sales Market Share by Application (2022-2027)
Table 110. Jemicare Corporation Information
Table 111. Jemicare Description and Business Overview
Table 112. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Jemicare Aminoglycosides Antibiotics Product
Table 114. Jemicare Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Teva Aminoglycosides Antibiotics Product
Table 119. Teva Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Aminoglycosides Antibiotics Product
Table 124. Novartis Recent Development
Table 125. Fangyuan-pharma Corporation Information
Table 126. Fangyuan-pharma Description and Business Overview
Table 127. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Fangyuan-pharma Aminoglycosides Antibiotics Product
Table 129. Fangyuan-pharma Recent Development
Table 130. Aike Pharmaceutical Corporation Information
Table 131. Aike Pharmaceutical Description and Business Overview
Table 132. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Aike Pharmaceutical Aminoglycosides Antibiotics Product
Table 134. Aike Pharmaceutical Recent Development
Table 135. Cipla Corporation Information
Table 136. Cipla Description and Business Overview
Table 137. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Cipla Aminoglycosides Antibiotics Product
Table 139. Cipla Recent Development
Table 140. Pfizer Corporation Information
Table 141. Pfizer Description and Business Overview
Table 142. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Pfizer Aminoglycosides Antibiotics Product
Table 144. Pfizer Recent Development
Table 145. Fresenius Kabi Corporation Information
Table 146. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Fresenius Kabi Description and Business Overview
Table 148. Fresenius Kabi Aminoglycosides Antibiotics Product
Table 149. Fresenius Kabi Recent Development
Table 150. Sun Pharma Corporation Information
Table 151. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Sun Pharma Description and Business Overview
Table 153. Sun Pharma Aminoglycosides Antibiotics Product
Table 154. Sun Pharma Recent Development
Table 155. Hikma Corporation Information
Table 156. Hikma Description and Business Overview
Table 157. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Hikma Aminoglycosides Antibiotics Product
Table 159. Hikma Recent Development
Table 160. Lannett Company Corporation Information
Table 161. Lannett Company Description and Business Overview
Table 162. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Lannett Company Aminoglycosides Antibiotics Product
Table 164. Lannett Company Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Aminoglycosides Antibiotics Distributors List
Table 168. Aminoglycosides Antibiotics Customers List
Table 169. Aminoglycosides Antibiotics Market Trends
Table 170. Aminoglycosides Antibiotics Market Drivers
Table 171. Aminoglycosides Antibiotics Market Challenges
Table 172. Aminoglycosides Antibiotics Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Aminoglycosides Antibiotics Product Picture
Figure 2. Global Aminoglycosides Antibiotics Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Aminoglycosides Antibiotics Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Post Care Facility Examples
Figure 9. Government & Military Examples
Figure 10. Others Examples
Figure 11. Global Aminoglycosides Antibiotics Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Aminoglycosides Antibiotics Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Aminoglycosides Antibiotics Sales (M Units) Growth Rate (2016-2027)
Figure 14. Global Aminoglycosides Antibiotics Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Aminoglycosides Antibiotics Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Aminoglycosides Antibiotics Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Aminoglycosides Antibiotics Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Aminoglycosides Antibiotics Sales (M Units) Growth Rate (2016-2027)
Figure 19. Europe Aminoglycosides Antibiotics Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Aminoglycosides Antibiotics Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Aminoglycosides Antibiotics Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Aminoglycosides Antibiotics Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Aminoglycosides Antibiotics Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Aminoglycosides Antibiotics Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Aminoglycosides Antibiotics Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Aminoglycosides Antibiotics Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Aminoglycosides Antibiotics Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Aminoglycosides Antibiotics Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Aminoglycosides Antibiotics Players Market Share by Revenue in Aminoglycosides Antibiotics: 2016 & 2020
Figure 30. Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Aminoglycosides Antibiotics Revenue Share by Type (2016-2021)
Figure 32. Global Aminoglycosides Antibiotics Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Aminoglycosides Antibiotics Revenue Share by Application (2016-2021)
Figure 34. Global Aminoglycosides Antibiotics Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 36. North America Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 37. Europe Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 38. Europe Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 39. China Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 40. China Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 41. Japan Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 42. Japan Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 43. Southeast Asia Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 44. Southeast Asia Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 45. India Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 46. India Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Aminoglycosides Antibiotics
Figure 49. Manufacturing Process Analysis of Aminoglycosides Antibiotics
Figure 50. Aminoglycosides Antibiotics Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
抗生物質＆抗真菌薬のグローバル市場調査 2019年 The global Antibiotics and Antimycotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antibiotics and Antimycotics volume and value at global level, regional level and company level. From a global…- 獣医用抗生物質のグローバル市場調査 2019年 The global Veterinary Antibiotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Veterinary Antibiotics volume and value at global level, regional level and company level. From a global perspective…
- 獣医用抗生物質のグローバル市場調査 2019年 The global Veterinary Antibiotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Veterinary Antibiotics volume and value at global level, regional level and company level. From a global perspective…
- 動物用抗生物質＆抗菌薬のグローバル市場調査 2019年 The global Animal Antibiotics and Antimicrobials market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Animal Antibiotics and Antimicrobials volume and value at global level, regional level and company le…
- 世界の全身性抗生物質市場規模・現状・予測（2021年-2027年） It refers to a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants that have anti-pathogens or other activities during their life, and can interfere with the development of other living cells. substance. Market Analysis an…